Rubicon Organics Inc (ROMJ)
TSX Venture Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 0.425 |
|---|---|
| 52-week range | 0.370 – 0.600 |
| Return, 1 month / 3 months | −9.6% / −7.6% |
| Return, 1 year / 3 years | −22.7% / −3.4% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 53.3% |
| Worst drawdown (1 year) | -28.8% |
| Average daily value traded | 0.04M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Rubicon Organics Inc is a licensed cannabis producer based in British Columbia, Canada. The company cultivates organic cannabis and prepares products such as dried flower, pre-rolled joints and extracts for the Canadian recreational and medical cannabis markets. Its brands include Simply Bare Organic and other labels aimed at consumers who prefer organically grown cannabis. Rubicon Organics focuses on certified organic growing methods and sells its products through provincial cannabis distributors and retailers across Canada.
The shares are listed on the TSX Venture Exchange in Canada under the code ROMJ, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Rubicon Organics Inc (ROMJ) trades on the TSX Venture Exchange in Canada. It last closed at CAD 0.425 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 249 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 22.7% and over the last three months it fell 7.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -10.9% | ||
| From 52-week high | -28.0% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.6% | ||
| 6-month return | -21.3% | ||
| 12-month return, skipping the last month | -14.5% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.8% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 0.04M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.4% |
|---|---|
| 1 month | −9.6% |
| 3 months | −7.6% |
| 6 months | −21.3% |
| 1 year | −22.7% |
| 3 years | −3.4% |
| 5 years | −83.1% |
Signals
| 50-day / 200-day average | 0.481 / 0.477 |
|---|---|
| Golden / death cross (60 days) | Golden, 35 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.014 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.